Literature DB >> 11080705

Latent adenoviral infection modifies the steroid response in allergic lung inflammation.

K Yamada1, W M Elliott, S Hayashi, R Brattsand, C Roberts, T Z Vitalis, J C Hogg.   

Abstract

BACKGROUND: Steroid-resistant asthma develops after adenoviral bronchiolitis.
OBJECTIVE: We sought to determine the effect of steroids on allergic lung inflammation in the presence of latent adenoviral infection.
METHODS: Guinea pigs with latent adenoviral (n = 12) or sham (n = 12) infections were sensitized and challenged with ovalbumin (OA) or sham sensitized and challenged with saline solution. The effect of steroids (20 mg/kg administered intraperitoneally) on OA-induced lung inflammation was examined by using quantitative histology as the outcome measure.
RESULTS: Latent adenoviral infection increased CD8(+) cells in the airway wall and CD8(+) cells, macrophages, B cells, and CD4(+) cells in the lung parenchyma. Ovalbumin challenge, on the other hand, increased eosinophils, macrophages, B cells, and CD4(+) cells in both the airway wall and lung parenchyma independent of the effect of latent adenoviral infection. In the sham-infected groups steroid treatment caused the expected reduction in the eosinophilic infiltrate induced by OA challenge in the airways without affecting the other cells. In the presence of both latent adenoviral infection and OA challenge, steroid treatment had no effect on allergen-induced eosinophilia but reduced CD8(+) cells in the airways and CD8(+) cells, CD4(+) cells, and B cells in the parenchyma.
CONCLUSION: Latent adenoviral infection and OA challenge result in different types of lung inflammation, and the presence of latent adenoviral infection causes OA-induced eosinophilic airway inflammation to become steroid resistant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080705     DOI: 10.1067/mai.2000.110473

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  Role of infections in the induction and development of asthma: genetic and inflammatory drivers.

Authors:  Qun Wu; Hong Wei Chu
Journal:  Expert Rev Clin Immunol       Date:  2009-01-01       Impact factor: 4.473

2.  Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation.

Authors:  Jason B Weinberg; Daniel R Jensen; Lisa E Gralinski; Amy R Lake; Gregory S Stempfle; Katherine R Spindler
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

Review 3.  Targeting airway smooth muscle in airways diseases: an old concept with new twists.

Authors:  Cynthia J Koziol-White; Gautam Damera; Reynold A Panettieri
Journal:  Expert Rev Respir Med       Date:  2011-12       Impact factor: 3.772

4.  Acute respiratory infection with mouse adenovirus type 1.

Authors:  Jason B Weinberg; Gregory S Stempfle; John E Wilkinson; John G Younger; Katherine R Spindler
Journal:  Virology       Date:  2005-09-30       Impact factor: 3.616

Review 5.  Transcriptional regulation of cytokine function in airway smooth muscle cells.

Authors:  Deborah Clarke; Gautam Damera; Maria B Sukkar; Omar Tliba
Journal:  Pulm Pharmacol Ther       Date:  2009-04-22       Impact factor: 3.410

6.  Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1.

Authors:  Omar Tliba; Gautam Damera; Audreesh Banerjee; Su Gu; Hasna Baidouri; Stefan Keslacy; Yassine Amrani
Journal:  Am J Respir Cell Mol Biol       Date:  2007-10-18       Impact factor: 6.914

Review 7.  Airway smooth muscle as an immunomodulatory cell.

Authors:  Gautam Damera; Omar Tliba; Reynold A Panettieri
Journal:  Pulm Pharmacol Ther       Date:  2008-12-24       Impact factor: 3.410

Review 8.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

9.  Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells.

Authors:  Reena Bhandare; Gautam Damera; Audreesh Banerjee; Jamie R Flammer; Stefan Keslacy; Inez Rogatsky; Reynold A Panettieri; Yassine Amrani; Omar Tliba
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-05       Impact factor: 6.914

10.  Heterogeneity of glucocorticoid resistance in patients with bronchial asthma.

Authors:  Yasuhiro Matsumura
Journal:  Int J Biomed Sci       Date:  2010-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.